The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Proton Pump Inhibitors Market Research Report 2025
Synopsis
Proton-pump inhibitors (PPIs) are a group of medications whose main action is a pronounced and long-lasting reduction of stomach acid production.
Proton pump inhibitors (PPIs) reduce the production of acid by blocking the enzyme in the wall of the stomach that produces acid. Acid is necessary for the formation of most ulcers in the esophagus, stomach, and duodenum, and the reduction of acid with PPIs prevents ulcers and allows any ulcers that exist in the esophagus, stomach, and duodenum to heal.
PPIs are among the most widely sold medications in the world. The class of proton-pump inhibitor medications is on the World Health Organization's List of Essential Medicines.
Medically used proton pump inhibitors: Omeprazole, Lansoprazole, Dexlansoprazole, Esomeprazole, Pantoprazole, Rabeprazole.
The global Proton Pump Inhibitors market was valued at US$ 12190 million in 2023 and is anticipated to reach US$ 9680.8 million by 2030, witnessing a CAGR of -3.2% during the forecast period 2024-2030.
Global Proton Pump Inhibitors key players include AstraZeneca, Takeda, etc. Global top two manufacturers hold a share over 15%.
North America is the largest market, with a share about 30%, followed by Asia-Pacific, and Europe, having a share about 50 percent.
In terms of product, Esomeprazole is the largest segment, with a share about 30%. And in terms of application, the largest application is Hospital Pharmacy, followed by Retail Pharmacy, etc.
This report aims to provide a comprehensive presentation of the global market for Proton Pump Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Proton Pump Inhibitors.
Report Scope
The Proton Pump Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Proton Pump Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Proton Pump Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.
Market Segmentation
By Company
Takeda
Pfizer
AstraZeneca
Bayer
Sun Pharma
Teva
Eisai Co.
Mylan
AOSAIKANG Pharma
Luoxin Pharma
LIVZON
Eastchina Pharma
Segment by Type
Dexlansoprazole
Esomeprazole
Lansoprazole
Omeprazole
Pantoprazole
Rabeprazole
Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Proton Pump Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Proton Pump Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Proton-pump inhibitors (PPIs) are a group of medications whose main action is a pronounced and long-lasting reduction of stomach acid production.
Proton pump inhibitors (PPIs) reduce the production of acid by blocking the enzyme in the wall of the stomach that produces acid. Acid is necessary for the formation of most ulcers in the esophagus, stomach, and duodenum, and the reduction of acid with PPIs prevents ulcers and allows any ulcers that exist in the esophagus, stomach, and duodenum to heal.
PPIs are among the most widely sold medications in the world. The class of proton-pump inhibitor medications is on the World Health Organization's List of Essential Medicines.
Medically used proton pump inhibitors: Omeprazole, Lansoprazole, Dexlansoprazole, Esomeprazole, Pantoprazole, Rabeprazole.
The global Proton Pump Inhibitors market was valued at US$ 12190 million in 2023 and is anticipated to reach US$ 9680.8 million by 2030, witnessing a CAGR of -3.2% during the forecast period 2024-2030.
Global Proton Pump Inhibitors key players include AstraZeneca, Takeda, etc. Global top two manufacturers hold a share over 15%.
North America is the largest market, with a share about 30%, followed by Asia-Pacific, and Europe, having a share about 50 percent.
In terms of product, Esomeprazole is the largest segment, with a share about 30%. And in terms of application, the largest application is Hospital Pharmacy, followed by Retail Pharmacy, etc.
This report aims to provide a comprehensive presentation of the global market for Proton Pump Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Proton Pump Inhibitors.
Report Scope
The Proton Pump Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Proton Pump Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Proton Pump Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.
Market Segmentation
By Company
Takeda
Pfizer
AstraZeneca
Bayer
Sun Pharma
Teva
Eisai Co.
Mylan
AOSAIKANG Pharma
Luoxin Pharma
LIVZON
Eastchina Pharma
Segment by Type
Dexlansoprazole
Esomeprazole
Lansoprazole
Omeprazole
Pantoprazole
Rabeprazole
Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Proton Pump Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Proton Pump Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Proton Pump Inhibitors Market Overview
1.1 Product Overview and Scope of Proton Pump Inhibitors
1.2 Proton Pump Inhibitors Segment by Type
1.2.1 Global Proton Pump Inhibitors Market Value Comparison by Type (2024-2030)
1.2.2 Dexlansoprazole
1.2.3 Esomeprazole
1.2.4 Lansoprazole
1.2.5 Omeprazole
1.2.6 Pantoprazole
1.2.7 Rabeprazole
1.3 Proton Pump Inhibitors Segment by Distribution Channel
1.3.1 Global Proton Pump Inhibitors Market Value by Distribution Channel: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Proton Pump Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Proton Pump Inhibitors Revenue 2019-2030
1.4.2 Global Proton Pump Inhibitors Sales 2019-2030
1.4.3 Global Proton Pump Inhibitors Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Proton Pump Inhibitors Market Competition by Manufacturers
2.1 Global Proton Pump Inhibitors Sales Market Share by Manufacturers (2019-2024)
2.2 Global Proton Pump Inhibitors Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Proton Pump Inhibitors Average Price by Manufacturers (2019-2024)
2.4 Global Proton Pump Inhibitors Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Proton Pump Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Proton Pump Inhibitors, Product Type & Application
2.7 Proton Pump Inhibitors Market Competitive Situation and Trends
2.7.1 Proton Pump Inhibitors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Proton Pump Inhibitors Players Market Share by Revenue
2.7.3 Global Proton Pump Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Proton Pump Inhibitors Retrospective Market Scenario by Region
3.1 Global Proton Pump Inhibitors Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Proton Pump Inhibitors Global Proton Pump Inhibitors Sales by Region: 2019-2030
3.2.1 Global Proton Pump Inhibitors Sales by Region: 2019-2024
3.2.2 Global Proton Pump Inhibitors Sales by Region: 2025-2030
3.3 Global Proton Pump Inhibitors Global Proton Pump Inhibitors Revenue by Region: 2019-2030
3.3.1 Global Proton Pump Inhibitors Revenue by Region: 2019-2024
3.3.2 Global Proton Pump Inhibitors Revenue by Region: 2025-2030
3.4 North America Proton Pump Inhibitors Market Facts & Figures by Country
3.4.1 North America Proton Pump Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Proton Pump Inhibitors Sales by Country (2019-2030)
3.4.3 North America Proton Pump Inhibitors Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Proton Pump Inhibitors Market Facts & Figures by Country
3.5.1 Europe Proton Pump Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Proton Pump Inhibitors Sales by Country (2019-2030)
3.5.3 Europe Proton Pump Inhibitors Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Proton Pump Inhibitors Market Facts & Figures by Country
3.6.1 Asia Pacific Proton Pump Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Proton Pump Inhibitors Sales by Country (2019-2030)
3.6.3 Asia Pacific Proton Pump Inhibitors Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Proton Pump Inhibitors Market Facts & Figures by Country
3.7.1 Latin America Proton Pump Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Proton Pump Inhibitors Sales by Country (2019-2030)
3.7.3 Latin America Proton Pump Inhibitors Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Proton Pump Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa Proton Pump Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Proton Pump Inhibitors Sales by Country (2019-2030)
3.8.3 Middle East and Africa Proton Pump Inhibitors Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Proton Pump Inhibitors Sales by Type (2019-2030)
4.1.1 Global Proton Pump Inhibitors Sales by Type (2019-2024)
4.1.2 Global Proton Pump Inhibitors Sales by Type (2025-2030)
4.1.3 Global Proton Pump Inhibitors Sales Market Share by Type (2019-2030)
4.2 Global Proton Pump Inhibitors Revenue by Type (2019-2030)
4.2.1 Global Proton Pump Inhibitors Revenue by Type (2019-2024)
4.2.2 Global Proton Pump Inhibitors Revenue by Type (2025-2030)
4.2.3 Global Proton Pump Inhibitors Revenue Market Share by Type (2019-2030)
4.3 Global Proton Pump Inhibitors Price by Type (2019-2030)
5 Segment by Distribution Channel
5.1 Global Proton Pump Inhibitors Sales by Distribution Channel (2019-2030)
5.1.1 Global Proton Pump Inhibitors Sales by Distribution Channel (2019-2024)
5.1.2 Global Proton Pump Inhibitors Sales by Distribution Channel (2025-2030)
5.1.3 Global Proton Pump Inhibitors Sales Market Share by Distribution Channel (2019-2030)
5.2 Global Proton Pump Inhibitors Revenue by Distribution Channel (2019-2030)
5.2.1 Global Proton Pump Inhibitors Revenue by Distribution Channel (2019-2024)
5.2.2 Global Proton Pump Inhibitors Revenue by Distribution Channel (2025-2030)
5.2.3 Global Proton Pump Inhibitors Revenue Market Share by Distribution Channel (2019-2030)
5.3 Global Proton Pump Inhibitors Price by Distribution Channel (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Proton Pump Inhibitors Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Proton Pump Inhibitors Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Proton Pump Inhibitors Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Proton Pump Inhibitors Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Sun Pharma
6.5.1 Sun Pharma Corporation Information
6.5.2 Sun Pharma Description and Business Overview
6.5.3 Sun Pharma Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sun Pharma Proton Pump Inhibitors Product Portfolio
6.5.5 Sun Pharma Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Proton Pump Inhibitors Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Eisai Co.
6.6.1 Eisai Co. Corporation Information
6.6.2 Eisai Co. Description and Business Overview
6.6.3 Eisai Co. Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eisai Co. Proton Pump Inhibitors Product Portfolio
6.7.5 Eisai Co. Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Proton Pump Inhibitors Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 AOSAIKANG Pharma
6.9.1 AOSAIKANG Pharma Corporation Information
6.9.2 AOSAIKANG Pharma Description and Business Overview
6.9.3 AOSAIKANG Pharma Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AOSAIKANG Pharma Proton Pump Inhibitors Product Portfolio
6.9.5 AOSAIKANG Pharma Recent Developments/Updates
6.10 Luoxin Pharma
6.10.1 Luoxin Pharma Corporation Information
6.10.2 Luoxin Pharma Description and Business Overview
6.10.3 Luoxin Pharma Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Luoxin Pharma Proton Pump Inhibitors Product Portfolio
6.10.5 Luoxin Pharma Recent Developments/Updates
6.11 LIVZON
6.11.1 LIVZON Corporation Information
6.11.2 LIVZON Proton Pump Inhibitors Description and Business Overview
6.11.3 LIVZON Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.11.4 LIVZON Proton Pump Inhibitors Product Portfolio
6.11.5 LIVZON Recent Developments/Updates
6.12 Eastchina Pharma
6.12.1 Eastchina Pharma Corporation Information
6.12.2 Eastchina Pharma Proton Pump Inhibitors Description and Business Overview
6.12.3 Eastchina Pharma Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Eastchina Pharma Proton Pump Inhibitors Product Portfolio
6.12.5 Eastchina Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Proton Pump Inhibitors Industry Chain Analysis
7.2 Proton Pump Inhibitors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Proton Pump Inhibitors Production Mode & Process
7.4 Proton Pump Inhibitors Sales and Marketing
7.4.1 Proton Pump Inhibitors Sales Channels
7.4.2 Proton Pump Inhibitors Distributors
7.5 Proton Pump Inhibitors Customers
8 Proton Pump Inhibitors Market Dynamics
8.1 Proton Pump Inhibitors Industry Trends
8.2 Proton Pump Inhibitors Market Drivers
8.3 Proton Pump Inhibitors Market Challenges
8.4 Proton Pump Inhibitors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
